Gamma Knife Market, By Indication (Brain Metastasis, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, Others), By Anatomy (Head, Neck, Others), By End User (Hospital, Clinics, Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023

Code : CMI408

Pages :210

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Gamma Knife Market: Key Developments

In October 2022, Elekta collaborated with Brainlab a medical technology company to enable neurosurgeons and radiation oncologists to use Brainlab’s iPlan software together with Elekta’s Leksell GammaPlan treatment planning for Gamma Knife radiosurgery. Through this collaboration, clinicians will be given the option to add the functionality of iPlan RT Image to the optimized dosimetry and precision of Leksell GammaPlan treatment planning.

In October 2021, Panacea Medical Technologies Pvt. Ltd. a medical equipment company received U.S. Food and Drug Administration (FDA) 510(k) clearance for its next generation stereotactic body radiotherapy (SBRT)-enabled linear accelerator on a ring gantry platform.

Global Gamma Knife Market: Key Trends

Incresing technological advancement: Increasing technological advancement by the market players is expected to drive the growth of the global gamma knife market over the forecast period. For instance, in August 16, 2023, GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services, launched its new dedicated website, www.gkfinancingllc.com, which aims to revolutionize the way healthcare professionals in neuroscience and radiosurgery access creative financing alternatives to obtain the Gamma Knife for non-invasive radiosurgery treatments.